S&P 500 7,541.73 â–ŧ 12.56 (-0.17%) DOW 52,155.52 ▲ 484.49 (+0.94%) NASDAQ 26,566.72 â–ŧ 117.23 (-0.44%) US Markets Open â€ĸ 12:31 PM ET

RTGN

RetinalGenix Technologies Inc.

Price Chart
Latest Quote

$4.00

+0.00 (+0.00%)
Current Price
Previous Close $4.00
Open $4.00
Day High $4.00
Day Low $4.00
Volume 19
Fetched: 2026-06-16T16:31:00
Stock Information
Shares Outstanding 18.84M
Total Debt $55K
Cash Equivalents $180
Net Income $-2.43M
Sector Healthcare
Industry Medical Devices
Market Cap $75.37M
EPS (TTM) $-0.13
Exchange PNK
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$75.43M
Income$-2.43M
Book/sh$-0.14
Cash/sh$0.00
Financial Ratios
Returns & Margins
ROA-17108.35%
Ownership
Insider Ownership65.30%
Insider & Institutional transactions data not available
Valuation Ratios
P/B-29.41
Analyst Data
Recommendationnone
Technical Indicators
SMA20$4.00
SMA50$3.68
SMA200$3.41
RSInan
Shares Float6.27M
Volatility-3.36
Performance History
Week+0.00%
Month+0.00%
Quarter+25.00%
6 Months+25.00%
YTD+25.00%
Year-20.32%
3 Years-55.56%
10 Years+33.33%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-15 $4.00 0
2026-06-12 $4.00 0
2026-06-11 $4.00 0
2026-06-10 $4.00 0
2026-06-09 $4.00 0
2026-06-08 $4.00 0
2026-06-05 $4.00 0
2026-06-04 $4.00 0
2026-06-03 $4.00 0
2026-06-02 $4.00 0
2026-06-01 $4.00 0
2026-05-29 $4.00 0
2026-05-28 $4.00 0
2026-05-27 $4.00 0
2026-05-26 $4.00 0
2026-05-22 $4.00 0
2026-05-21 $4.00 0
2026-05-20 $4.00 0
2026-05-19 $4.00 0
2026-05-18 $4.00 0
About RetinalGenix Technologies Inc.

RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders. The company offers the Retinal Imaging Screening Device, a portable retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCam, an in-home/remote location patient-activated monitoring and imaging device offering real-time communication and alerting system for physicians. It also develops RTG-2023 for the treatment of dry age-related macular degeneration; and RTG-2024 for the treatment of Alzheimer's syndrome dementia. The company was incorporated in 2017 and is based in Apollo Beach, Florida. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.

📰 Latest News
No news articles available at the moment. Check back later for updates on RTGN.
Period:
Loading...
Income Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
Reconciled Cost Of Revenue $703,930 $403,658 $370,523 $361,580
Cost Of Revenue $703,930 $403,658 $370,523 $361,580
Total Revenue $0 $0 $0 $0
Operating Revenue $0 $0 $0 $0
Expenses
Interest Expense $3,840 $3,840 $5,140 $2,619
Total Expenses $4,316,987 $2,087,049 $1,875,961 $2,176,675
Net Non Operating Interest Income Expense $-3,840 $-3,840 $-5,140 $-2,619
Interest Expense Non Operating $3,840 $3,840 $5,140 $2,619
Operating Expense $3,613,057 $1,683,391 $1,505,438 $1,815,095
General And Administrative Expense $3,239,786 $1,159,208 $696,183 $1,067,287
Other Income Expense - - $-2,032,889 $-680,293
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-4,320,827 $-2,090,889 $-3,913,990 $-2,179,294
Net Interest Income $-3,840 $-3,840 $-5,140 $-2,619
Normalized Income $-4,320,827 $-2,090,889 $-1,881,101 $-2,179,294
Net Income From Continuing And Discontinued Operation $-4,320,827 $-2,090,889 $-3,913,990 $-2,179,294
Net Income Common Stockholders $-4,320,827 $-2,090,889 $-3,913,990 $-2,179,294
Net Income $-4,320,827 $-2,090,889 $-3,913,990 $-2,179,294
Net Income Including Noncontrolling Interests $-4,320,827 $-2,090,889 $-3,913,990 $-2,179,294
Net Income Continuous Operations $-4,320,827 $-2,090,889 $-3,913,990 $-2,179,294
Pretax Income $-4,320,827 $-2,090,889 $-3,913,990 $-2,179,294
Operating Income $-4,316,987 $-2,087,049 $-1,875,961 $-2,176,675
Gross Profit $-703,930 $-403,658 $-370,523 $-361,580
Special Income Charges - $0 $-2,032,889 $0
Per Share
Diluted EPS $-0.24 $-0.12 $-0.25 $-0.15
Basic EPS $-0.24 $-0.12 $-0.25 $-0.15
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-4,316,033 $-2,086,949 $-1,875,910 $-2,176,675
Reconciled Depreciation $954 $100 $51 $0
EBITDA (Bullshit earnings) $-4,316,033 $-2,086,949 $-3,908,799 $-2,176,675
EBIT $-4,316,987 $-2,087,049 $-3,908,850 $-2,176,675
Diluted Average Shares $17,940,639 $17,352,196 $15,584,346 $14,282,314
Basic Average Shares $17,940,639 $17,352,196 $15,584,346 $14,282,314
Diluted NI Availto Com Stockholders $-4,320,827 $-2,090,889 $-3,913,990 $-2,179,294
Research And Development $373,271 $524,183 $809,255 $747,808
Selling General And Administration $3,239,786 $1,159,208 $696,183 $1,067,287
Other Gand A $630,000 $495,000 $436,883 $759,369
Salaries And Wages $2,609,786 $664,208 $259,300 $307,918
Total Unusual Items - $0 $-2,032,889 $0
Total Unusual Items Excluding Goodwill - $0 $-2,032,889 $0
Other Special Charges - - $2,032,889 $680,293
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Net Tangible Assets $-1,462,610 $-1,405,657 $-1,069,063 $-464,675
Total Assets $14,946 $156 $294 $4,947
Total Non Current Assets $8,886 $156 $256 $0
Non Current Prepaid Assets $1,995 $0 - -
Current Assets $6,060 $0 $38 $4,947
Cash Cash Equivalents And Short Term Investments $6,060 $0 $38 $4,947
Cash And Cash Equivalents $6,060 $0 $38 $4,947
Cash Financial $6,060 $0 $38 $4,947
Current Deferred Assets - - - $0
Receivables - - - $0
Debt
Net Debt $42,940 $49,000 $48,962 $68,053
Total Debt $56,532 $49,000 $49,000 $73,000
Long Term Debt And Capital Lease Obligation $6,544 $0 - -
Current Debt And Capital Lease Obligation $49,988 $49,000 $49,000 $73,000
Current Debt $49,000 $49,000 $49,000 $73,000
Liabilities
Total Liabilities Net Minority Interest $1,477,556 $1,405,813 $1,069,357 $469,622
Total Non Current Liabilities Net Minority Interest $6,544 $0 $0 $0
Current Liabilities $1,471,012 $1,405,813 $1,069,357 $469,622
Current Notes Payable $49,000 $49,000 $49,000 $73,000
Payables And Accrued Expenses $1,421,024 $1,356,813 $1,020,357 $396,622
Interest Payable $15,439 $11,599 $7,759 $2,619
Payables $1,405,585 $1,345,214 $1,012,598 $394,003
Accounts Payable $922,083 $884,920 $475,480 $251,282
Equity
Common Stock Equity $-1,462,610 $-1,405,657 $-1,069,063 $-464,675
Total Equity Gross Minority Interest $-1,462,610 $-1,405,657 $-1,069,063 $-464,675
Stockholders Equity $-1,462,610 $-1,405,657 $-1,069,063 $-464,675
Other Equity Interest $-150,000 - - -
Retained Earnings $-15,430,022 $-11,109,195 $-9,018,306 $-5,104,316
Other
Ordinary Shares Number $18,522,295 $17,635,478 $17,272,116 $14,282,314
Share Issued $18,522,295 $17,635,478 $17,272,116 $14,282,314
Tangible Book Value $-1,462,610 $-1,405,657 $-1,069,063 $-464,675
Invested Capital $-1,413,610 $-1,356,657 $-1,020,063 $-391,675
Working Capital $-1,464,952 $-1,405,813 $-1,069,319 $-464,675
Capital Lease Obligations $7,532 $0 - -
Total Capitalization $-1,462,610 $-1,405,657 $-1,069,063 $-464,675
Additional Paid In Capital $14,115,560 $9,701,774 $7,947,460 $4,638,218
Capital Stock $1,852 $1,764 $1,783 $1,423
Common Stock $1,852 $1,764 $1,783 $1,423
Preferred Stock $0 $0 $0 $0
Long Term Capital Lease Obligation $6,544 $0 - -
Current Capital Lease Obligation $988 $0 - -
Current Accrued Expenses $15,439 $11,599 $7,759 $2,619
Dueto Related Parties Current $483,502 $460,294 $537,118 $142,721
Net PPE $6,891 $156 $256 $0
Accumulated Depreciation $-251 $-151 $-51 $0
Gross PPE $7,142 $307 $307 $0
Other Properties $307 $307 $307 -
Buildings And Improvements $6,835 $0 - -
Properties $0 $0 - -
Treasury Shares Number - $0 - -
Duefrom Related Parties Current - - - $0
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow
Free Cash Flow $-741,936 $-451,661 $-199,287 $-1,166,971
Operating Activities
Operating Cash Flow $-741,936 $-451,661 $-199,287 $-1,166,971
Cash Flow From Continuing Operating Activities $-741,936 $-451,661 $-199,287 $-1,166,971
Investing Activities
Investing Cash Flow - $0 $-307 $0
Capital Expenditure - - $-307 -
Cash Flow From Continuing Investing Activities - - $-307 $0
Financing Activities
Issuance Of Capital Stock $503,088 $0 $60,500 $1,083,199
Financing Cash Flow $747,996 $451,623 $194,685 $1,169,699
Cash Flow From Continuing Financing Activities $747,996 $451,623 $194,685 $1,169,699
Net Other Financing Charges $34,908 $451,623 $109,185 -
Net Common Stock Issuance $503,088 $0 $60,500 $1,083,199
Common Stock Issuance $503,088 $0 $60,500 $1,083,199
Other
Interest Paid Supplemental Data $0 $0 $0 -
Income Tax Paid Supplemental Data $0 $0 $0 -
End Cash Position $6,060 $0 $38 $4,947
Beginning Cash Position $0 $38 $4,947 $2,219
Changes In Cash $6,060 $-38 $-4,909 $2,728
Proceeds From Stock Option Exercised $210,000 $0 $25,000 $13,500
Change In Working Capital $188,851 $413,280 $230,338 $156,257
Change In Other Working Capital $-1,995 - - $43,787
Change In Other Current Liabilities $-157 $0 - -
Change In Payables And Accrued Expense $191,003 $413,280 $230,338 $112,470
Change In Accrued Expense $3,840 $3,840 $5,140 $2,619
Change In Interest Payable $3,840 $3,840 $5,140 $2,619
Change In Payable $187,163 $409,440 $225,198 $109,851
Change In Account Payable $187,163 $409,440 $225,198 $109,851
Other Non Cash Items $779,300 $561,640 $3,225,014 $548,148
Stock Based Compensation $2,609,786 $664,208 $259,300 $307,918
Depreciation Amortization Depletion $954 $100 $51 $0
Depreciation And Amortization $954 $100 $51 $0
Depreciation $954 $100 $51 $0
Net Income From Continuing Operations $-4,320,827 $-2,090,889 $-3,913,990 $-2,179,294
Issuance Of Debt - - $0 $73,000
Net Issuance Payments Of Debt - - $0 $73,000
Net Short Term Debt Issuance - - $0 $73,000
Short Term Debt Issuance - - $0 $73,000
Net PPE Purchase And Sale - - $-307 $0
Purchase Of PPE - - $-307 $0
Net Long Term Debt Issuance - - - $73,000
Long Term Debt Issuance - - - $73,000
Fetched: 2026-02-02